Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abide, accretion, agent, ameliorate, anemic, anogenital, API, arm, bid, blinded, blood, campaign, centralized, certified, cheaper, chemistry, clarity, closer, Commerce, compliant, consecutive, crossover, danazol, database, deal, Delegated, delist, delisted, delisting, device, diarrhea, EC, economy, ESMO, esophageal, extrinsic, Fast, faster, fatigue, hoc, inclusion, justification, language, legitimate, logistical, lt, lung, methodology, mild, moderate, MOMENTUM, naive, nausea, NCCN, neutropenia, notable, notified, notify, nurse, ofpre, owe, PDCO, perception, pharmacovigilance, placebo, portal, post, prespecified, proceed, prolonged, qualification, questionnaire, RACE, randomized, RAS, ratio, RECIST, red, regain, rejected, reluctance, SD, seemingly, Shield, shipping, shutdown, Stable, symptomatic, TEAE, technical, thrombocytopenia, tolerability, tolerated, TSS, unblinding, uponour, vendor, vomiting, Week, wholly
Removed:
approximately, bioavailability, broadening, declared, dependency, dysregulated, elevated, facilitating, FileNo, genomic, Importantly, induced, innovative, intravenously, Janssen, leading, lethal, lethality, machinery, niraparib, persistent, polymerase, prostate, pursuing, repair, survival, synergistic, synthetic, synthetically, underwriting, wave
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view